申请人:——
公开号:US20030087924A1
公开(公告)日:2003-05-08
The invention provides dicarboxylic acid-substituted heteroaryl derivatives of the formula
G
1
-(C(R
1
)R
2
)
n
-Q
1
-B-Q
2
-(C(R
3
)R
4
)
m
-G
2
I
or a pharmaceutically acceptable salt thereof, wherein G
1
, G
2
, R
1
, R
2
, R
3
, R
4
, n, m, Q
1
, Q
2
, and B are as defined in the specification. The invention compounds are inhibitors of matrix metalloproteinase enzymes, including MMP-13. This invention also provides pharmaceutical compositions and methods of treating diseases mediated by MMP-13, including arthritis, asthma, heart disease, atherosclerosis, and osteoporosis, or a pharmaceutically acceptable salt thereof.
该发明提供了公式G1-(C(R1)R2)n-Q1-B-Q2-(C(R3)R4)m-G2的二羧酸取代的杂环衍生物,或其药用可接受的盐,其中G1、G2、R1、R2、R3、R4、n、m、Q1、Q2和B如规范中所定义。该发明化合物是基质金属蛋白酶酶的抑制剂,包括MMP-13。该发明还提供了药物组合物和治疗由MMP-13介导的疾病的方法,包括关节炎、哮喘、心脏病、动脉粥样硬化和骨质疏松症,或其药用可接受的盐。